Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin T Low

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Methods (San Diego, Calif.)|June 18, 2010
SHAPE-directed RNA secondary structure predictionJustin T Low, Kevin M Weeks
CNS Oncology|March 7, 2020
Ibrutinib in primary central nervous system diffuse large B-cell lymphomaJustin T Low, Katherine B Peters
Current Neurology and Neuroscience Reports|May 19, 2022
Advances in the Diagnosis and Treatment of Leptomeningeal DiseaseAkanksha Sharma, Justin T Low, Priya Kumthekar
Advances in Radiation Oncology|November 8, 2021
Pineal Parenchymal Tumors of Intermediate Differentiation Treated With Ventricular Radiation and TemozolomideJustin T Low, John P Kirkpatrick, Katherine B Peters
The Journal of Clinical Investigation|December 2, 2024
Taking the STING out of radiotherapy: STING checkpoints mediate radiation resistanceMichael C Brown, Justin T Low, Michelle L Bowie, et al.
Viruses|May 27, 2026
Epstein-Barr Virus-Positive Primary CNS Lymphoma in a Patient Receiving Mycophenolate Mofetil: Diagnostic and Therapeutic ConsiderationsDanielle N Burner, Giselle Y López, Justin T Low, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2012
SHAPE-directed discovery of potent shRNA inhibitors of HIV-1Justin T Low, Stefanie A Knoepfel, Joseph M Watts, et al.
Biochemistry|June 14, 2014
Structure and dynamics of the HIV-1 frameshift element RNAJustin T Low, Pablo Garcia-Miranda, Kathryn D Mouzakis, et al.
Neuro-Oncology Practice|May 23, 2022
Primary brain and other central nervous system tumors in the United States (2014-2018): A summary of the CBTRUS statistical report for cliniciansJustin T Low, Quinn T Ostrom, Gino Cioffi, et al.
Oncotarget|June 10, 2025
Beyond DNA damage response: Immunomodulatory attributes of CHEK2 in solid tumorsHelen Qian, Heba Ali, Vivekanudeep Karri, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Methods (San Diego, Calif.)|June 18, 2010
SHAPE-directed RNA secondary structure predictionJustin T Low, Kevin M Weeks
CNS Oncology|March 7, 2020
Ibrutinib in primary central nervous system diffuse large B-cell lymphomaJustin T Low, Katherine B Peters
Current Neurology and Neuroscience Reports|May 19, 2022
Advances in the Diagnosis and Treatment of Leptomeningeal DiseaseAkanksha Sharma, Justin T Low, Priya Kumthekar
Advances in Radiation Oncology|November 8, 2021
Pineal Parenchymal Tumors of Intermediate Differentiation Treated With Ventricular Radiation and TemozolomideJustin T Low, John P Kirkpatrick, Katherine B Peters
The Journal of Clinical Investigation|December 2, 2024
Taking the STING out of radiotherapy: STING checkpoints mediate radiation resistanceMichael C Brown, Justin T Low, Michelle L Bowie, et al.
Viruses|May 27, 2026
Epstein-Barr Virus-Positive Primary CNS Lymphoma in a Patient Receiving Mycophenolate Mofetil: Diagnostic and Therapeutic ConsiderationsDanielle N Burner, Giselle Y López, Justin T Low, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2012
SHAPE-directed discovery of potent shRNA inhibitors of HIV-1Justin T Low, Stefanie A Knoepfel, Joseph M Watts, et al.
Biochemistry|June 14, 2014
Structure and dynamics of the HIV-1 frameshift element RNAJustin T Low, Pablo Garcia-Miranda, Kathryn D Mouzakis, et al.
Neuro-Oncology Practice|May 23, 2022
Primary brain and other central nervous system tumors in the United States (2014-2018): A summary of the CBTRUS statistical report for cliniciansJustin T Low, Quinn T Ostrom, Gino Cioffi, et al.
Oncotarget|June 10, 2025
Beyond DNA damage response: Immunomodulatory attributes of CHEK2 in solid tumorsHelen Qian, Heba Ali, Vivekanudeep Karri, et al.
Pageof 2